Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities.

MLA

Bashyal, Krishna Prasad, et al. “Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities.” International Journal of Rheumatology, vol. 2024, Mar. 2024, pp. 1–9. EBSCOhost, https://doi.org/10.1155/2024/6650921.

APA

Bashyal, K. P., Shah, S., Ghimire, C., Balmuri, S., Chaudhary, P., Karki, S., Poudel, A. K., Pokharel, A., Devarkonda, V., & Hayat, S. (2024). Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities. International Journal of Rheumatology, 2024, 1–9. https://doi.org/10.1155/2024/6650921

Chicago

Bashyal, Krishna Prasad, Sangam Shah, Calvin Ghimire, Shravya Balmuri, Pradip Chaudhary, Sandip Karki, Anuj Krishna Poudel, Ashbina Pokharel, Vishal Devarkonda, and Samina Hayat. 2024. “Primary Immune Thrombocytopenic Purpura (ITP) and ITP Associated with Systemic Lupus Erythematosus: A Review of Clinical Characteristics and Treatment Modalities.” International Journal of Rheumatology 2024 (March): 1–9. doi:10.1155/2024/6650921.